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Abstract: The core components of regenerative medicine are stem cells with high self-renewal
and tissue regeneration potentials. Adult stem cells can be obtained from many organs and
tissues. NANOG, SOX2 and OCT4 represent the core regulatory network that suppresses
differentiation-associated genes, maintaining the pluripotency of mesenchymal stem cells. The roles
of NANOG in maintaining self-renewal and undifferentiated status of adult stem cells are still
not perfectly established. In this study we define the effects of downregulation of NANOG in
maintaining self-renewal and undifferentiated state in mesenchymal stem cells (MSCs) derived
from subcutaneous adipose tissue (hASCs). hASCs were expanded and transfected in vitro with
short hairpin Lentivirus targeting NANOG. Gene suppressions were achieved at both transcript
and proteome levels. The effect of NANOG knockdown on proliferation after 10 passages and
on the cell cycle was evaluated by proliferation assay, colony forming unit (CFU), qRT-PCR and
cell cycle analysis by flow-cytometry. Moreover, NANOG involvement in differentiation ability
was evaluated. We report that downregulation of NANOG revealed a decrease in the proliferation
and differentiation rate, inducing cell cycle arrest by increasing p27/CDKN1B (Cyclin-dependent
kinase inhibitor 1B) and p21/CDKN1A (Cyclin-dependent kinase inhibitor 1A) through p53 and
regulate DLK1/PREF1. Furthermore, NANOG induced downregulation of DNMT1, a major DNA
methyltransferase responsible for maintaining methylation status during DNA replication probably
involved in cell cycle regulation. Our study confirms that NANOG regulates the complex transcription
network of plasticity of the cells, inducing cell cycle arrest and reducing differentiation potential.
Keywords: human adipose stem cell; NANOG; cell cycle regulation; DNMT1; lentiviral transduction
1. Introduction
OCT4, SOX2 and NANOG are the actors in the complex machinery that regulate pluripotency of
mesenchymal stem cells [1]. Expression of OCT4 and NANOG is restricted to pluripotent cells,
and they are downregulated upon differentiation [2,3]. OCT4 and NANOG work together to
maintain pluripotency without LIF (Leukemia inhibitory factor) [4] and studies confirm that NANOG
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downregulation induces ESCs (Embryonic stem cell) differentiation into extraembryonic lineages [5,6].
Wang et al. showed that OCT4 and NANOG maintain self-renewal and block differentiation in ESCs [7];
however, little is known about their mechanism in adult mesenchymal stem cells. Adipose stem cells
(ASCs) represent an alternative source of mesenchymal stem cells that can be easily and safely obtained
from adipose tissue, growing under appropriate culture conditions for a long time [8–10]. As previously
shown, ASCs express CD29, CD90, CD105 and CD73 and are negative for the hematopoietic endothelial
markers CD34, CD45, CD117, and HLA-DR [11–14]. Nowadays, it is more important to understand
the mechanisms through which maintain the proliferation, differentiation and heterogeneity of these
cells [15,16]. OCT4, SOX2 and NANOG have also been suggested to play a similar role as embryonic
stem cells in adult mesenchymal cells, including human Adipose Stem Cells (hASCs). In our previous
studies, we found that the embryonic stem cell marker NANOG is over-expressed in MSCs derived
from adipose tissue and its silencing with a RNA interference technology causes downregulation of
OCT4 and SOX2 gene expression [13], confirming recent studies that have demonstrated a central role
of NANOG in regulating stem cells’ multipotent properties [15,17].
DLK1 (PREF1) is a marker used to characterized mouse preadipocyte progenitors which inhibits
adipogenesis, suppressingC/EBPβ andC/EBPδ gene expression [18–23]. Recently, DLK1 (PREF1) proved
to be a useful marker for human ASCs [24,25] and methylation regulates its expression. One of the
DNA methyltransferase that regulates the DNA methylation during replication is the DNMT1 [25] and
ESCs differentiation and embryo development are regulate by DNA methylation. A recent study [26]
demonstrated that NANOG directly binds to the promoter of DNMT1 [26] and enhances its expression.
In this study, our aim was to investigate the role of NANOG in maintaining the proliferation and
differentiation potential of ASCs after downregulation of NANOG with a Lentivirus system and to
examine the expression of some important genes related to cell growth control such as p27/CDKN1B,
p21/CDKN1A, CCDN1 and PREF1. We show that NANOG downregulation induced a decrease in the
proliferation rate and differentiation potential and led to cell cycle arrest in G0/G1 by regulating CCDN1,
p21/CDKN1A and p27/CDKN1B through p53 and a PREF1 inhibition, inducing loss of pluripotency
via DNMT1.
2. Results
2.1. hASC Isolation and Characterization
Enzymatic digestion of biopsied human adipose tissue was obtained after consent from 20 patients
(nine men and 11 women; age 45 ± 10 years; with body mass index (BMI) range 28 ± 3) undergoing
elective open-abdominal surgery. As previously published, hASC highly expressed THY1, CD105
and CD73 and all of the ESC markers SOX-2, OCT4 and NANOG (see Table S1 in Supplementary).
When cultured in adhesion we observed the formation of colonies of fibroblastic-like cells, whereas in
low-adhesion culture conditions spheres were formed (Figure 1).
2.2. Knockdown of NANOG Silencing by Lentivirus
To evaluate the roles of NANOG in maintaining stem cell properties we studied changes in
stem cell marker gene expression in hASCs lentiviral transducted with shRNA against NANOG.
The mRNA and protein expression level of NANOG after 10 and 15 days of antibiotic selection
after shRNA infection was evaluated by quantitative PCR and western blot analysis. As observed
in Figure 2A, the NANOG mRNA level decreased by almost 90 ± 3.5% in cell lines infected with
NANOG shRNA lentivirus as compared to the control group (hASCs CNT, freshly isolated hASCs at
passage 4, and hASCs transducted with scrambled shRNA against NANOG, hASC negative shRNA
NANOG). Furthermore, Figure 2B showed the downregulation of NANOG protein expression after
15-day antibiotic selection, by almost 76 ± 2.3% in hASCs infected with NANOG shRNA lentivirus
(Optical Density (OD) = 0.87 ± 0.9 versus 0.2 ± 0.06). The quantitative analysis of western blot bands
was performed using ImageJ. In our previous studies we found that the embryonic stem cell marker
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NANOG is over-expressed in hASCs and its silencing causes downregulation of the OCT4 and SOX2
genes. As assessed by real-time RT-PCR, we confirm that NANOG mRNA in freshly hASC is highly
expressed and NANOG knockdown induces OCT4 and SOX2 downregulation, indicating loss of
pluripotency in hASCs (data shown in Supplementary Materials).
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Figure 1. hASC morphology on day 5 (A) of expansion culture observed under light microscopy 
(10×) with phase contrast with a Nikon DS-FI1 CCD camera. Scale bar = 10μm. (B) Shows the 
formation of hASC colonies when cultured in adhesion, Scale bar = 10μm, while (C) shows spheres 
which formed when hASCs were cultured in low adhesion culture conditions, Scale bar = 10μm. A 
representative experiment referring to 23 samples studied. (D) qRT-PCR analysis in freshly isolated 
hASCs at passage 4 of THY1, CD73, CD105, OCT4, SOX2 and NANOG gene expression compared to 
ASC52telo, hTERT immortalized adipose-derived mesenchymal stem cells. Data shown are relative 
to an endogenous control (beta-Actin). Relative expression levels were assessed using the 2−ΔΔCt 
method. Values are shown as the mean ± SE. Data are representative of three independent 
experiments. 
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Materials). 
Figure 1. hASC morphology on day 5 (A) of expansion culture observed under light microscopy (10×)
with phase contrast with a Nikon DS-FI1 CCD camera. Scale bar = 10µm. (B) Shows the formation of
hASC colonies when cultured in adhesion, Scale bar = 10µ , while (C) shows spheres which formed
when hASCs were cultured in low adhesion culture conditions, Scale bar = 10µm. A representative
experiment referring to 23 samples studied. (D) qRT-PCR analysis in freshly isolated hASCs at passage
4 of THY1, CD73, CD105, OCT4, SOX2 and NANOG gene expression compared to ASC52telo, hTERT
immortalized adipose-derived mesenchymal stem cells. Data shown are relative to an endogenous
control (beta-Actin). Relative expression levels were assessed using the 2−∆∆Ct method. Values are
shown as the mean ± SE. Data are representative of three independent experiments.
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Figure 2. Freshly isolated hASCs at passage 4 (hASCs CNT), hASCs lentivirally transducted with 
scrambled (negative) or shRNA against NANOG. (A) qRT-PCR analysis for NANOG gene 
expression after 10-day antibiotic selection. Relative expression levels were assessed using the 
2−ΔΔCt method. Data are representative of three independent experiments with the fold change 
compared to expression levels in a commercial human adipose stem cell line (ASC52telo, hTERT 
immortalized adipose-derived mesenchymal stem cells). Values are shown as the mean ± SE, ** p < 
0.01. (B,C) Western blot analysis for protein expression of NANOG after 15 days of antibiotic 
selection. Values are shown as mean ± SE, ** p < 0.01. 
Figure 2. Freshly isolated hASCs at passage 4 (hASCs CNT), hASCs lentivirally transducted with
scrambled (negative) or shRNA against NANOG. (A) qRT-PCR analysis for NANOG gene expression
after 10-day antibiotic selection. Relative expression levels were assessed using the 2−∆∆Ct method.
Data are representative of three independent experiments with the fold change compared to expression
levels in a commercial human adipose ste cell line (ASC52telo, hTERT immortalized adipose-derived
mesenchymal st m cells). Valu s ar shown as the mean ± SE, ** p < 0.01. (B,C) Western blot analysis
for protein expression of NANOG after 15 days of antibiotic selection. Values are shown as mean ± SE,
** p < 0.01.
2.3. Analysis of PREF1
In order better to understand the differentiation potential of hASCs biology, we studied the effect
of NANOG shRNA knockdown on DLK1/PREF1 gene expression. We found that PREF1 mRNA was
downregulated (0.8 ± 0.03 versus 0.3 ± 0.06, p < 0.01) in hASCs with NANOG downregulated (Figure 3).
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control cells, and after three days, this difference became more evident (Figure 4A). 
Downregulation of NANOG reduces the number of the colonies. As shown in Figure 4B, the 
clonogenicity of ASCs transfected with shRNA lentivirus NANOG decreased, according to the 
number of cell colonies. The colony formation rate of NANOG shRNA-infected cells was 8.5 ± 3.6%, 
lower than that of freshly isolated hASCs at passage 4 (hASCs CNT) and scrambled sh NANOG 
tranfected cells (hASCs negative sh NANOG) (** p < 0.01) and the results show an increase in the 
population doubling time (Figure 4C). ASCs with NANOG knockdown also show a decrease in 
adipogenic differentiation potential (Figure 4D). Taken together, hASCs transducted with shRNA 
against NANOG decrease in proliferation capacity and differentiation potential, indicating that 
NANOG has a role in regulation of stem cell properties. 
Figure 3. qRT-PCR analysis of PREF1 gene expression in freshly isolated hASCs at passage 4
(hASCs CNT), hASCs lentivirally transducted with scrambled (negative) and shRNA against NANOG
(hASCs sh NANOG). PREF1 was significantly downregulated in hASCs sh NANOG. Relative expression
levels were assessed using the 2−∆∆Ct method. Data are representative of three independent experiments
with the fold change compared to expression levels in a commercial human adipose stem cell line
(ASC52telo, hTERT immortalized adipose-derived mesenchymal stem cell). The experiment was
repeated at least three times ** p < 0.01.
2.4. Downregulation of NANOG Inhibited Cell Proliferation, Increased Population Doubling Time and Reduced
Differentiation Pote tial
The effects of NANOG knockdown on ASCs proliferation were assessed using trypan blue assay
and Colony Forming Unit ability. Cell proliferation analysis sh ws that the hASCs transducted with
shRNA against NANOG grew significantly more slowly than wild-type cells and control cells, and after
three days, this difference became more evident (Fi ure 4A). Downregulation of NANOG reduces the
number of the colonies. As s own in Figure 4B, the clonogenicity of ASCs transfected with shRNA
lentivirus NANOG decreased, according to the number of cell c lonies. The colony formation rate of
NANOG shRNA-infected cells was 8.5 ± 3.6%, lower than that of freshly isolated hASCs at passage 4
(hASCs CNT) and scrambled sh NANOG tra fected cells (hASCs negative sh NANOG) (** p < 0.01)
and the results show an increase in the population doubling time (Figure 4C). ASCs wit
knockdown also show a decrease in adipogenic differentiation potential (Figure 4D). Taken together,
hASCs trans ucted with shRNA against NANOG decrease in proliferation capacity and differentiation
potential, in icating that NANOG has a role in regulation of stem cell properties.
2.5. Knockdown of NANOG Inhibited the Expression of CCND1/Cycline D1, Enhanced the Expression of p21
and p27 and Induced Cell Cycle Block in the G0/G1 Phase
We evaluated the effects of NANOG knockdown on the growth capability of ASCs, and our results
confirm that in NANOG knockdown the percentage of cells in G0/G1 phase increased from 48 ± 3.2%
for freshly isolated hASCs at passage 4 (hASCs CNT) and 52 ± 1.8% for hASCs scrambled shRNA
to 70.5 ± 1.2% (NANOG knockdown group), while the percentage of S phase cells decreased from
45 ± 2.3% for freshly isolated hASCs at passage 4 and 48% for scrambled (negative shRNA NANOG) to
20% (NANOG knockdown group). (Figure 5A) These results indicated that downregulation of NANOG
expression arrested hASCs in the G0/G1 phase. Consistent with these observations, downregulation
of NANOG induced a reduction of the proliferation rate as indicated by the proliferation index
(P.I.) 0.52 ± 0.06% in hASCs negative for shRNA against NANOG versus P.I 0.23 ± 0.001 in hASCs
transfected with shRNA against NANOG. To investigate the G0/G1 phase arrest we evaluated the
principal genes involved in cell proliferation, p27/CDKN1B (Cyclin-dependent kinase inhibitor 1B)
p21/CDKN1A (Cyclin-dependent kinase inhibitor 1A) and CYCLINE D1 by qRT-PCR. Interestingly,
as shown in Figure 5, knockdown of NANOG in hASCs increased expression of the CDKN1B and
CDKN1A (1.8 ± 0.08-fc and 3.8±0.05-fc, respectively, ** p < 0.01) mRNA level when compared to the
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negative sh NANOG and freshly isolated hASCs at passage 4 (hASCs CNT) (0.85 ± 0.05). Significant
downexpression of CYCLINE D1 in mRNA levels was detected (0.63 ± 0.09-fc, ** p < 0.01).Int. J. Mol. Sci. 2019, 20, x FOR P ER REVIEW 6 of 13 
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(75 ± 5 versus 40 ± 5). (C) The population doubling time analysis. (D) Shows the differentiation 
potential into adipogenic lineage: (a) hASCs at passage 4 differentiated into adipocytes, (b) hASCs 
scrambled sh NANOG tranfected cells (hASCs negative sh NANOG) differentiated into adipocytes 
and (c) hASCs lentivirally transducted with shRNA against NANOG differentiated into adipocytes. 
Cultures were observed under light microscopy (10×) with phase contrast with a Nikon DS-FI1 CCD 
camera. scale bar=10μm (Values are mean ± SD, ** p < 0.01). A representative photograph of the 
colonies formed 14 days after lentivirus transfection, stained with crystal violet, is shown in 
Supplementary Materials. 
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We evaluated the effects of NANOG knockdown on the growth capability of ASCs, and our 
results confirm that in NANOG knockdown the percentage of cells in G0/G1 phase increased from 
48 ± 3.2% for freshly isolated hASCs at passage 4 (hASCs CNT) and 52 ± 1.8% for hASCs scrambled 
shRNA to 70.5 ± 1.2% (NANOG knockdown group), while the percentage of S phase cells decreased 
from 45 ± 2.3% for freshly isolated hASCs at passage 4 and 48% for scrambled (negative shRNA 
NANOG) to 20% (NANOG knockdown group). (Figure 5A) These results indicated that 
downregulation of NANOG expression arrested hASCs in the G0/G1 phase. Consistent with these 
observations, downregulation of NANOG induced a reduction of the proliferation rate as indicated 
by the proliferation index (P.I.) 0.52 ± 0.06% in hASCs negative for shRNA against NANOG versus 
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Figure 4. Time-dependent effects of downregulation of NANOG on hASCs growth, colony formation
ability, population doubling time and differentiation potential. (A) Shows the cell growth rate over a
72-h peri d in fres ly is lated hASCs at passage 4 (ASC CNT), h s lentivirally tra sduced with
scramble (n gative NANOG) or shRNA against NANOG using the trypan blue viabili y assay. (B) The
clone numbers (more than 50 cells) of the freshly isolated hASCs at passage 4 (AS CNT) and hASCs
negative ShNANOGwere much higher than that of the hASCs shNANOG (75± 5 versus 40± 5). (C) The
population doubling time analysis. (D) Shows the differentiation potential into adipogenic lineage:
(a) hASCs at passage 4 differentiated into adipocytes, (b) hASCs scrambled sh NANOG tranfected cells
(hASCs negative sh NANOG) differentiated into adipocytes and (c) hASCs lentivirally transducted with
shRNA against NANOG differentiated into adipocytes. Cultures were observed under light microscopy
(10×) with phase contrast with a Nikon DS-FI1 CCD camera. scale bar=10µm (Values are mean ± SD,
** p < 0.01). A representative photograph of the colonies formed 14 days after lentivirus transfection,
stained with crystal violet, is shown in Supplementary Materials.
2.6. Knockdown of NANOG Regulates DNMT1
To clarify the role of p53 in regulation of p21 and p27 gene expression in hASCs with NANOG
downregulated we evaluated p53 mR A expression. Our findings onfirmed that freshly isolated
hASCs at passage 4 expressed p53 and NANOG downregulation induced a significant change in p53
(0.5 ± 0.08-fc * p < 0.05) gene expression, as shown in Figure 6A. DNA methylation seems to play an
essential role in regulating ESC differentiation and embryo development and DNMT-mediated CpG
methylation has been demonstrated to play a distinct role in cell cycle regulation. To investigate the
possible involvement of DNMTs in cell cycle arrest we evaluated expression of the DNMT1 protein in
hASCs lentivirally transduced with shRNA targeting NANOG. We found that DNMT1 protein levels
were dramatically reduce in hASCs with NANOG knockdown compared to freshly isolated hASCs at
passage 4 and to hASCs scrambled (optical density (OD) = 0.2 ± 0.03 versus 0.4 ± 0.06). (Figure 6B,C).
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cell cycle distribution of hASCs according t Nicoletti’s protocol. (B) and (C) Real-time PCR analyses
showed that expression of the cell cycle protein CDKN1A and CDKN1B were significantly increased in
hASCs with NANOG downregulated while the expression of CYCLINE D1 was downregulated (D).
Flow cytometry analyses showed that downregulation of NANOG induced a decrease in the proportion
of G2/M + S phase cells in hASCs sh NANOG as compared to freshly isolated hASCs at passage 4
(hASCs CNT). All experiments were repeated at least three times. (Values are mean ± SD, ** p < 0.01).Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 8 of 13 
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Figure 6. (A) qRT-PCR of p53 gene expression in in freshly isolated hASCs at passage 4 (hASCs CNT),
hASCs lentivirally transducted with scrambled (negative) and shRNA against NANOG (hASCs sh
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hASCs. Relative expression le ls were assess d using the 2−∆∆Ct method. Data are representative of
three independent experiments with the fold change compared to expression levels in a commercial
human adipose stem cell line (ASC52telo, hTERT immortalized adipose-derived mesenchymal stem
cell). The experiment was repeated at least three times * p < 0.05. (B) Representative western blot
analysis for expression of DNMT1. Densitometric analysis of the Western blot depicted in (C). The
histograms are the results of three independent experiments. The values are shown as the mean ± SE,
** p < 0.01. OD, optical density (** p < 0.01).
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3. Discussion
The properties of stem cells are indicated as the ability to proliferate and to preserve an
undifferentiated state and the capacity to differentiate toward multiple cell lineages. It is well
known that SOX2 OCT4 and NANOG are the core of “pluripotency” machinery. Our previous study
suggested that NANOG is an essential transcriptional regulator of genes involved in maintaining
undifferentiated pluripotent state of hASCs, but few data exist to conclude that the hASCs fate and
differentiation potential are regulated by this protein. In this study hASCs were isolated from biopsies
of subcutaneous adipose tissue undergoing elective open-abdominal surgery and were characterized
for stem cell markers CD90, CD105 and CD73, and then, cells were transducted with short hairpin
Lentivirus system targeting NANOG, which resulted in significant downregulation of NANOG gene
and protein expression. Inhibition of NANOG led to a significant downregulation of OCT4 and
SOX2, as previously demonstrated [13], and we were able to detect a decrease in expression of the
adipose stem cell marker DLK/PREF1. Knockdown of NANOG in hASCs reduced cell proliferation
rate and differentiation potential, inducing cell cycle arrest in G0/G1. p21/CDKN1A and p27/CDKN1B
are proteins of the Cip/Kip family that act as key cell cycle regulators by inhibiting CDK [27,28].
To understand the roles of NANOG in cell cycle arrest, we examined p21 and p27 gene expression.
We demonstrate that downregulation of NANOG in hASCs induced an increase of p27 and p21
gene expression. Recent studies have identified CDK1 as an essential in vivo target of p27 [29] and
our in vitro study confirms that CCND1 gene expression is reduced. It is well known that p21 and
p27 expression is regulated largely at the transcriptional level by a p53-dependent mechanism [30],
which suggests that NANOG may regulate expression of these “player” genes through the p53 tumor
suppressor gene. Our experiments confirmed that NANOG downregulation induced a reduction of
p53 gene expression, suggesting that NANOG can regulate p21 and p27 activity through p53 activity.
Furthermore, it is well known that p21 and p27 are regulated by methylation [31,32] and DNA
methylation regulate the expression of appropriate genes in ESCs [31]. Previous experiments have
shown in methylation-deficient mouse embryos (DNMT1−/−, DNMT3a−/− and DNMT3b−/−) that the
restoring of DNA methylation is essential for development [31–33]. One of the most important DNA
methyltransferases is DNMT1, which is responsible for maintaining methylation status during DNA
replication, and a recent study demonstrated that NANOG directly binds to the promoter of DNMT1
in ESCs and enhances its expression [26]. To determine whether NANOG-mediated maintenance of
stem cell properties in hASC came about through regulation of DNMT1, we evaluated DNMT1 protein
expression. The results confirm that NANOG downregulation induced a reduction of DNMT1 protein
expression. In conclusion, our results demonstrate that inhibition of NANOG not only decreased
hASCs growth and induced the arrest of the cell cycle, but also induced a reduction of differentiation
ability. Moreover, our results confirm that the stem cell transcription factor NANOG regulated cell
cycle progression probably via p53, which directly controls p21 and p27, key regulator factors of
cell cycle machinery. Furthermore, through DNMT1 NANOG can methylate PREF1, which induces
differentiation and can modulate the methylation status of p21 and p27 as previously described.
All these data suggest that NANOG is essential for maintaining hASCs properties.
4. Materials and Methods
4.1. Cell Culture and Cell Infection with Lentiviral Particles
Subcutaneous (SAT) adipose tissue biopsies were obtained from 23 consenting patients (10 men,
13 women; age 40± 10; BMI range between 28± 3) undergoing elective open-abdominal and laparoscopy
surgery. The protocol was approved by the Independent Ethical Committee (no. 08/2018; 27 August
2018) at the P. Giaccone Azienda Ospedaliera Universitaria Policlinico, Palermo, Italy. All patients gave
their written informed consent. Adipose tissue was processed as previously described [13]. Primary
cells were used at passage 4 for all experiments. The commercial primary cell line immortalized
with a human telomerase reverse transcriptase (ASC52telo, hTERT) (ATCC®SCRC-4000™, American
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Type Culture Collection, Manassas, VA, USA) was cultured in Mesenchymal Stem Cell Basal Medium
(ATCC PCS-500-030).supplemented with Mesenchymal Stem Cell Growth Kit (ATCC PCS-500-040,
LGC Standards, Milan, Italy). For lentivirus infection, 2× 104 hASCs were seeded in six-well plates, and
infected with lentivirus (sc-43958-V, Santa Cruz Biotechnology, DBA, Milan, Italy with a the multiplicity
of infection (MOI) 10 in the presence of 8 µg/mL polybrene (sc-134220, Santa Cruz Biotechnology).
At 24 h after infection, the media were removed and replaced with fresh growth media. After 48 h
the media were replaced with fresh growth media containing puromycin (1 µg/mL, cod. P9620,
Sigma Aldrich, Milan, Italy) to select for infected cells. All experiments were performed 10–15 days
after puromycin selection.
4.2. RNA Isolation and Quantitative RT-PCR
RNA was isolated in columns from subconfluent cultures of hASC by RNeasy kit (Qiagen,
Hamburg, Germany) as previously described [13]. Gene expression was normalized for the
housekeeping gene beta-actin (Invitrogen, Milan, Italy). Amplification of specific transcripts was
confirmed by melting curve profiles at the end of each PCR. PCR primersNANOG (QT01844808),OCT3/4
(QT00210840), SOX2 (QT00237601), THY1 (QT00023569), CD105 (QT00013335), CD73 (QT00027279), p53
(QT00060235), CCDN1 (QT00495285), CDKN1A (QT00062090), CDKN1B (QT00998445) were purchased
from Qiagen (QuantiTect ®Primer Assays, Qiagen, Hamburg, Germany), β-Actin (FORWARD:
5′-GGACTT CGA GCA AGA GAT GG-3′ REVERSE: 5′-AGC ACT GTG TTG GCG TAC AG-3′)
was purchased from Invitrogen. All reactions were performed using the Quantitect SYBR Green
PCR Kit (cod. 204243, Qiagen) on the RotorGene Q Instrument (Qiagen) as previously described.
Gene expression of primary cells was compared with a commercial primary cell line immortalized
with a human telomerase reverse transcriptase (ASC52telo, hTERT) ATCC®SCRC-4000™, American
Type Culture Collection, Manassas, VA, USA), as positive cell controls. Relative expression levels for
each gene were assessed using the 2−∆∆Ct method. The results were represented as histograms with
GraphPad Prism 6 Software (GraphPad Software, Inc., La Jolla, CA, USA). qRT-PCR analyses for the
stem gene were also performed after lentivirus infection experiments.
4.3. Western Blot Analysis
Proteins were extracted from adherent cultured cells and separated as previously
described [13,34,35]. The antibodies used are as described in Table 1. The secondary antibody was
goat anti-mouse IgG-HRP (Amersham, GE Healthcare Europe GmbH, Milan, Italy). Antigen-antibody
complexes were visualized using the ECL prime (Amersham, GE Healthcare Europe GmbH, Milan,
Italy) on a CCD camera (Chemidoc, Bio-Rad, Milan, Italy). Western blot bands were quantified
with ImageJ 1.48 software (National Institutes of Health, Bethesda, MD, USA) and the results were
represented as histograms with GraphPad Prism 6 Software (GraphPad Software, Inc., La Jolla,
CA, USA).
Table 1. Primary antibodies used.
Primary Antibody/Localization Marker Code Number Diluition Incubation
NANOG, nuclear and cytoplasmatic sc-293121, Santa Cruz Biotechnology 1:500 o/n, 4 ◦C
DNMT1, nuclear sc-271729, Santa Cruz Biotechnology 1:500 o/n, 4 ◦C
B-Actin clone AC-74 A5316, Sigma Aldrich 1:10,000 o/n, 4 ◦C
4.4. Analysis of Cell Cycle Status of MSCs with Lentivirus
Single-cell suspensions of control samples and transfected samples were obtained and seeded
at a density of 2 × 103 cells/cm2 (passage 3), and the DNA content was assessed according to
Nicoletti’s protocol [36] as previously described [13]. Data were acquired with CellQuest Pro software
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(Becton Dickinson, Milan, Italy) and the percentages of G1, S and G2 phase cells were calculated with
the MODFIT-LT 5.0 software program (Verity Software House Inc., Topsham, ME, USA).
4.5. Colony-Forming Assay
Single-cell suspension ASCs cell lines were seeded in a six-well culture in DMEM/Ham’s F12 1:1
supplemented with 100 unit/mL penicillin, 0.1 mg/mL streptomycin and 10% fetal calf serum (FCS) at
a density of 300 cells/well and cultured at 37 ◦C in 5% CO2. After 14 days, the cells were fixed in 4%
paraformaldehyde (Sigma Aldrich) and stained with 0.1% crystal violet (Sigma Aldrich). Only the
cell groups containing more than 50 cells were considered as colonies. Numbers of colonies were
quantified with ImageJ 1.48 software (National Institutes of Health, Bethesda, MD, USA).
4.6. Population Doubling and Cell Proliferation Curve
Cell proliferation curve and population doubling time were assessed as previously described [35].
The doubling time (DT) was calculated in accordance with the literature data (http://www.doubling-
time.com/compute.php). Three sets of experiments for each sample were used for calculations.
5. Conclusions
We examined whether NANOG contributes to maintaining cells in an undifferentiated, pluripotent
state by activating certain key genes and by silencing others. For this purpose, hASCs were transfected
with a lentivirus with shRNA targeting NANOG and our results suggest that NANOG plays a key
role in the hASCs proliferation rate by increasing the expression of p21 and p27 and by modulating
PREF1. In conclusion, we confirm that NANOG is an important player in the complex transcription
network that regulates pluripotency. We hypothesized that p21, p27 and PREF1 may be regulated by
DNMT1, a promotor that is directly bound by NANOG, as demonstrated by Tsai et al. [26]. Further
experiments are needed to establish the pathway to explain the involvement of NANOG in the control
of cell cycle progression.
Supplementary Materials: Supplementary Materials can be found at http://www.mdpi.com/1422-0067/20/10/
2580/s1.
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